Abhay Joshi Insider Trading $RVNC Revance Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Abhay Joshi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Abhay Joshi. Abhay Joshi is EVP & Chief Technical Officer in COTHERIX INC ($CTRX) and EVP, Chief Technical Officer in COTHERIX INC ($CTRX) and Chief Operating Officer in Revance Therapeutics, Inc. ($RVNC) and COO, President of R&D in Revance Therapeutics, Inc. ($RVNC) and COO, President, R&D in Revance Therapeutics, Inc. ($RVNC).
Abhay Joshi in Revance Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Abhay Joshi: COO, President of R&D, COO, President, R&D, Chief Operating Officer
Holdings: 128,368 shares
Current Value: $2,657,218
Latest Transaction: Mar 17 2021
$RVNC Market Capitalization: $591.69M
$RVNC Previous Close: $20.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Abhay Joshi in Revance Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2021 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Payment of Exercise | F | 27.73 | 1,354 | 37,546 | 128,368 | 129.7 K to 128.4 K (-1.04 %) |
| Feb 19 2021 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Payment of Exercise | F | 28.97 | 2,881 | 83,463 | 129,722 | 132.6 K to 129.7 K (-2.17 %) |
| Feb 19 2021 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Payment of Exercise | F | 28.97 | 1,967 | 56,984 | 132,603 | 134.6 K to 132.6 K (-1.46 %) |
| Feb 04 2021 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Option Exercise | A | 28.01 | 40,925 | 1,146,309 | 40,925 | |
| Feb 04 2021 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Grant | A | 0.00 | 22,620 | 0 | 134,570 | 112 K to 134.6 K (+20.21 %) |
| Oct 02 2020 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Payment of Exercise | F | 25.14 | 7,382 | 185,583 | 111,950 | 119.3 K to 112 K (-6.19 %) |
| Oct 02 2020 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Grant | A | 0.00 | 17,500 | 0 | 119,332 | 101.8 K to 119.3 K (+17.19 %) |
| Mar 17 2020 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President of R ... | Payment of Exercise | F | 15.50 | 1,354 | 20,987 | 101,832 | 103.2 K to 101.8 K (-1.31 %) |
| Feb 19 2020 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Payment of Exercise | F | 25.33 | 3,325 | 84,222 | 103,186 | 106.5 K to 103.2 K (-3.12 %) |
| Jan 24 2020 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Option Exercise | A | 22.32 | 146,500 | 3,269,880 | 146,500 | |
| Jan 24 2020 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Grant | A | 0.00 | 25,000 | 0 | 106,511 | 81.5 K to 106.5 K (+30.67 %) |
| Jan 17 2020 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Payment of Exercise | F | 22.89 | 4,441 | 101,654 | 81,511 | 86 K to 81.5 K (-5.17 %) |
| Dec 17 2019 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Payment of Exercise | F | 15.99 | 2,971 | 47,506 | 85,952 | 88.9 K to 86 K (-3.34 %) |
| Mar 18 2019 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Option Exercise | M | 4.20 | 666 | 2,797 | 0 | |
| Mar 18 2019 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Payment of Exercise | F | 15.45 | 1,354 | 20,919 | 88,923 | 90.3 K to 88.9 K (-1.50 %) |
| Mar 18 2019 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Payment of Exercise | F | 15.59 | 166 | 2,588 | 90,277 | 90.4 K to 90.3 K (-0.18 %) |
| Mar 18 2019 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Buy | M | 4.20 | 666 | 2,797 | 90,443 | 89.8 K to 90.4 K (+0.74 %) |
| Feb 20 2019 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Payment of Exercise | F | 17.69 | 1,510 | 26,712 | 89,777 | 91.3 K to 89.8 K (-1.65 %) |
| Feb 20 2019 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Payment of Exercise | F | 17.69 | 1,510 | 26,712 | 89,777 | 91.3 K to 89.8 K (-1.65 %) |
| Jan 25 2019 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Option Exercise | A | 17.23 | 94,000 | 1,619,620 | 94,000 | |
| Jan 25 2019 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Grant | A | 0.00 | 15,750 | 0 | 91,287 | 75.5 K to 91.3 K (+20.85 %) |
| Jan 17 2019 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Payment of Exercise | F | 20.19 | 4,466 | 90,169 | 75,537 | 80 K to 75.5 K (-5.58 %) |
| Dec 14 2018 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Payment of Exercise | F | 19.91 | 4,260 | 84,817 | 80,003 | 84.3 K to 80 K (-5.06 %) |
| Mar 23 2018 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Option Exercise | M | 2.55 | 666 | 1,698 | 0 | |
| Mar 23 2018 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Buy | M | 2.55 | 666 | 1,698 | 84,263 | 83.6 K to 84.3 K (+0.80 %) |
| Mar 23 2018 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Option Exercise | M | 2.55 | 666 | 1,698 | 0 | |
| Mar 23 2018 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Buy | M | 2.55 | 666 | 1,698 | 84,263 | 83.6 K to 84.3 K (+0.80 %) |
| Feb 16 2018 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Payment of Exercise | F | 31.75 | 1,509 | 47,911 | 83,597 | 85.1 K to 83.6 K (-1.77 %) |
| Feb 09 2018 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Option Exercise | A | 29.15 | 70,500 | 2,055,075 | 70,500 | |
| Feb 09 2018 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Grant | A | 0.00 | 11,750 | 0 | 85,106 | 73.4 K to 85.1 K (+16.02 %) |
| Jan 17 2018 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Payment of Exercise | F | 34.50 | 4,327 | 149,282 | 73,356 | 77.7 K to 73.4 K (-5.57 %) |
| Dec 18 2017 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Payment of Exercise | F | 32.15 | 3,229 | 103,812 | 77,683 | 80.9 K to 77.7 K (-3.99 %) |
| Jan 30 2017 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Option Exercise | A | 19.70 | 79,000 | 1,556,300 | 79,000 | |
| Jan 30 2017 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Grant | A | 0.00 | 13,100 | 0 | 80,912 | 67.8 K to 80.9 K (+19.32 %) |
| Dec 16 2016 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Grant | A | 0.00 | 36,000 | 0 | 67,812 | 31.8 K to 67.8 K (+113.16 %) |
| Dec 16 2016 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Payment of Exercise | F | 16.70 | 3,229 | 53,924 | 31,812 | 35 K to 31.8 K (-9.21 %) |
| Aug 16 2016 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Option Exercise | M | 6.60 | 666 | 4,396 | 0 | |
| Aug 16 2016 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Buy | M | 6.60 | 666 | 4,396 | 35,041 | 34.4 K to 35 K (+1.94 %) |
| Dec 16 2015 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Option Exercise | A | 36.32 | 206,250 | 7,491,000 | 206,250 | |
| Dec 16 2015 | RVNC | Revance Therapeuti ... | Joshi Abhay | Chief Operating Off ... | Grant | A | 0.00 | 34,375 | 0 | 34,375 | 0 to 34.4 K |
Page: 1